Successful slow tocilizumab desensitization in a patient with adult onset Still disease

Biologicals. 2018 Sep:55:17-18. doi: 10.1016/j.biologicals.2018.07.002. Epub 2018 Jul 14.

Authors

Tuba Erdogan¹, Nazife Sule Yasar Bilge², Timucin Kasifoglu³

Affiliations

¹ Eskisehir Osmangazi University, Medical Faculty, Department of Chest Disease, Division of Immunology and Allergy, Turkey.
² Eskisehir Osmangazi University, Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Turkey. Electronic address: suleyasar@yahoo.com.
³ Eskisehir Osmangazi University, Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Turkey.

PMID: 30017556
DOI: 10.1016/j.biologicals.2018.07.002

No abstract available

Keywords: Adult onset Still disease; Desensitization; Tocilizumab.

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / administration & dosage*
Desensitization, Immunologic*
Female
Humans
Still's Disease, Adult-Onset / drug therapy*
Still's Disease, Adult-Onset / immunology
Still's Disease, Adult-Onset / pathology

Substances

Antibodies, Monoclonal, Humanized
tocilizumab